C68.0

Clinical Causes: The exact cause of malignant neoplasm of the urethra is not clearly understood. However, several factors may contribute to the development of urethral cancer: - Chronic inflammation or infections of the urethra - History of radiation therapy in the pelvic region - Previous history of cancer in nearby tissues - Exposure to certain chemicals or carcinogens - Age-related cellular changes, as the risk increases with age - Pre-existing conditions such as urethral diverticula or strictures - In women, conditions like urethritis or urethral caruncle potentially increasing risk In many cases, the development of urethral cancer involves complex interactions between genetic and environmental factors. Notably, the condition is more prevalent in men than women, particularly in those over the age of 50.

Key Symptoms: Symptoms of malignant neoplasm of the urethra can vary based on the tumor's size and location but may include: - Blood in the urine (hematuria) - Pain or a burning sensation during urination - A palpable mass or lump along the urethra - Discomfort or pain in the pelvic area - A feeling of incomplete urination or urinary retention - Discharge from the urethral opening - Changes in urinary habits, such as increased frequency or urgency Since these symptoms can also be associated with other, less serious conditions, early medical evaluation is essential for appropriate diagnosis.

Diagnosis Path: Diagnosing malignant neoplasm of the urethra involves a combination of clinical assessments and laboratory tests: - Medical history review and physical examination - Urinalysis to detect blood or abnormal cells in the urine - Imaging studies, such as ultrasound, CT scans, or MRI, to visualize the tumor - Cystourethroscopy, providing direct visualization of the urethra and bladder through a thin, flexible tube - Biopsy of the tissue sample obtained during cystoscopy, for histopathological examination - Additional tests, including urine cytology, may assist in confirming diagnosis Early diagnosis is crucial to determine the extent of the disease and plan appropriate treatment strategies.

Treatment Protocols: Treatment options for malignant neoplasm of the urethra depend on the size, location, stage, and overall health of the patient: - Surgical removal of the tumor, which may include local excision or more extensive urethrectomy - Radiation therapy to eliminate cancer cells or reduce tumor size - Chemotherapy, often used in advanced cases or when the cancer has spread - Combining treatments, such as surgery followed by radiation or chemotherapy, for better outcomes - Targeted therapy or immunotherapy may be considered in select cases The choice of treatment is individualized and requires a multidisciplinary team of healthcare professionals to determine the best approach for each patient. Post-treatment follow-up is essential to monitor for recurrence and manage any side effects.